OMedLive

CME Presentations

Chronic Lymphocytic Leukemia


Presentations

  • CME
    1.0

    Challenges and Practical Considerations for Relapsed Refractory CLL

    Speakers:Susan O'Brien, MD, Associate Director for Clinical Science
    Julie Vose, MD, MBA, Professor, Internal Medicine

    Duration: 60 minutes

    Presented on: January 12, 2018

  • CME
    1.0

    Roadmap to Managing Relapse Refractory CLL Now and in the Future

    Speakers:Ian W. Flinn, MD, PhD, Director, Hematologic Malignancies Research Program
    Julie Vose, MD, MBA, Professor, Internal Medicine

    Duration: 60 minutes

    Presented on: January 12, 2018


Speakers

  • Susan O'Brien, MD

    Susan O'Brien, MD

    Susan O'Brien, MD

    Associate Director for Clinical Science

    Susan O’Brien, MD, is associate director for clinical science for the Chao Family Comprehensive Cancer Center, and medical director of the Sue and Ralph Stern Center for Cancer Clinical Trials and Research at UC Irvine Health in Irvine, California. Specializing in hematology and medical oncology, Dr O’Brien oversees and coordinates clinical cancer research across the entire UC Irvine Health organization, with her clinical expertise being in the diagnosis and treatment of leukemia. She has been principal investigator for more than 40 funded clinical research protocols, and has authored numerous articles in peer-reviewed journals, invited articles, and book chapters and abstracts. She earned her medical degree from the University of Medicine and Dentistry of New Jersey in Newark.
  • Julie Vose, MD, MBA

    Julie Vose, MD, MBA

  • Ian W. Flinn, MD, PhD

    Ian W. Flinn, MD, PhD

    Ian W. Flinn, MD, PhD

    Director, Hematologic Malignancies Research Program

    Ian W. Flinn, MD, PhD, is the director of lymphoma research at the Sarah Cannon Center for Blood Cancer in Nashville, Tennessee, where he oversees blood cancer research throughout Sarah Cannon and its affiliates. He is also the director for the Sarah Cannon Center for Blood Cancer at Tennessee Oncology and TriStar Centennial Medical Center. Dr Flinn received his medical degree from Johns Hopkins University School of Medicine in Baltimore, Maryland, followed by an internship and residency at the University of Michigan Medical Center in Ann Arbor. He completed a fellowship in oncology and hematology, and earned a PhD in clinical investigations from Johns Hopkins University School of Medicine. Dr Flinn is board-certified in hematology and medical oncology.

CME Information